Bafna Pharmaceuticals Limited — Others, 09-01-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

BAFNA Pharmaceuticals has announced a board meeting to discuss the financial results for the quarter and half-year ended December 31, 2024. The company is complying with regulatory requirements by providing a certificate regarding the dematerialization of securities for this period. This update indicates active management of shareholder processes, ensuring transparency and adherence to regulations. Investors might view this as a positive outlook, reflecting the company's commitment to maintaining operational effectiveness and efficient capital structure.